Clinical trials
Withdrawn Thrombocytopenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| GlaxoSmithKline | 1 |
| Hutchmed | 1 |
| Kezar Life Sciences, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Northwestern University | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 1 |
| Susan Smyth | 1 |
| University Hospital Tuebingen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 14 |
| Anemia | 4 |
| COVID-19 | 2 |
| Hematologic Diseases | 2 |
| Hemolysis | 2 |
| Purpura, Thrombocytopenic, Idiopathic | 2 |
| Sepsis | 2 |
| Thrombotic Microangiopathies | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.